Last update 19 Jun 2026

T-Cell therapy(H. Lee Moffitt Cancer Center and Research Institute)

Overview

Basic Info

Drug Type
T-lymphocyte cell therapy
Synonyms
HER2 specific T cells, IL-15 expanded CD4 T cells, IL-7 expanded CD4 T cells
Target
HER2
Action
modulators
Mechanism
HER2 modulators(Receptor tyrosine-protein kinase erbB-2 modulators)
Therapeutic Areas
NeoplasmsSkin and Musculoskeletal Diseases
Active Indication-
Inactive Indication
Metastatic human epidermal growth factor 2 positive carcinoma of breast
Originator Organization
H. Lee Moffitt Cancer Center & Research Institute, Inc.H. Lee Moffitt Cancer Center & Research Institute, Inc.
Active Organization-
Inactive Organization
H. Lee Moffitt Cancer Center & Research Institute, Inc.H. Lee Moffitt Cancer Center & Research Institute, Inc.
License Organization-
Drug Highest PhaseSuspendedPhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with T-Cell therapy(H. Lee Moffitt Cancer Center and Research Institute)
NCT05378464
/ SuspendedPhase 1IIT
Phase 1 Study of Adoptive T Cell Therapy Following HER2-Pulsed Dendritic Cell Vaccine and Pepinemab / Trastuzumab in Patients With Metastatic HER2-Positive Breast Cancer
100 Clinical Results associated with T-Cell therapy(H. Lee Moffitt Cancer Center and Research Institute)
Login to view more data
100 Translational Medicine associated with T-Cell therapy(H. Lee Moffitt Cancer Center and Research Institute)
Login to view more data
100 Patents (Medical) associated with T-Cell therapy(H. Lee Moffitt Cancer Center and Research Institute)
Login to view more data
100 Deals associated with T-Cell therapy(H. Lee Moffitt Cancer Center and Research Institute)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Metastatic human epidermal growth factor 2 positive carcinoma of breastPhase 1
United States
H. Lee Moffitt Cancer Center & Research Institute, Inc.H. Lee Moffitt Cancer Center & Research Institute, Inc.
31 May 2022
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free